NFE2L2 and atherosclerosis: Liver fibrosis/hepatic stellate cell activation, LXR/RXR activation, FXR/RXR activation, atherosclerosis signaling, NRF2-mediated oxidation stress response, HIF1α signaling, and gap junction signaling were enriched (Figure 3(b)).